Article Text

Download PDFPDF
Radiotherapeutic management in carcinoma of the uterine cervix: current status
  1. R. Y. Kim
  1. Department of Radiation Oncology, University of Alabama Medical Center, Birmingham, Alabama, USA
  1. Address for correspondence: Professor Robert Y. Kim, MD, Department of Radiation Oncology, University of Alabama Medical Center. 619 So. 19th St. Birmingham, AL 35233, USA.


Despite refinement in the delivery of external radiation and brachytherapy, there has been little improvement in the survival rate of patients with invasive cancer of the uterine cervix in recent years. With advancing stage disease, there is an increase in both local failure and distant metastases. Although recent efforts to improve local control for late stage disease have been encouraging, research efforts should be directed to the identification of new active drugs for radiation sensitization and systemic therapy. Also, due to early detection, therapeutic investigations should focus on the high-risk subsets of patients with early stage disease.

  • carcinoma of the cervix
  • radiotherapy.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.